ImmuPharma PLC

London, England, United Kingdom immupharma.co.uk

Overview

ImmuPharma PLC is a biopharmaceutical company engaged in the discovery and development of novel drugs to treat serious medical conditions, primarily in the fields of autoimmune diseases and cancer. The company's lead product is in late-stage development targeting lupus, a chronic autoimmune disease.

Therapeutic areas

Autoimmune DiseasesOncology

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to ImmuPharma PLC in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

Immunocore Holdings Plc
United Kingdom
3t Biosciences
United States
Akeso, Inc.
China
Argenx SE
Belgium
Biocad
Russia
Biocon Limited
India
Celltrion, Inc.
South Korea
Chemeleon, Inc.
United States

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo